Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Crown

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
BMJ (Clinical Research Ed.)|July 5, 1997
Britain's first minister of public health. National public health research and development programme is neededJ Crown, M Clarke
Seminars in Oncology|December 29, 1998
Phase III studies of single-agent docetaxel in patients with metastatic breast cancer who have progressed despite previous chemotherapy regimens: preliminary resultsJ M Nabholtz, J Crown
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2012
Emerging targeted therapies in triple-negative breast cancerJ Crown, J O'Shaughnessy, G Gullo
Psycho-Oncology|September 19, 1998
The use of psychotropic medication in patients referred to a psycho-oncology serviceR Cullivan, J Crown, N Walsh
Leukemia & Lymphoma|April 1, 1993
Interleukin-1: biological effects in human hematopoiesisJ Crown, A Jakubowski, J Gabrilove
The Health Service Journal|February 22, 1990
A climate of trustP Howden-Chapman, A Waterfall, J Crown
Irish Medical Journal|November 1, 1995
Metastatic bone disease: role of bisphosphonatesM J McKenna, R Freaney, J Crown
British Journal of Hospital Medicine|September 1, 1989
Development of clinical auditJ Secker-Walker, H Purser, J Crown
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancerB Corkery, J Crown, M Clynes, et al.
Hematological Oncology|July 1, 1987
Large cell transformation of subclinical small lymphocytic leukemia/lymphoma: a variant of Richter's syndromeJ A Strauchen, M M May, J Crown
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
BMJ (Clinical Research Ed.)|July 5, 1997
Britain's first minister of public health. National public health research and development programme is neededJ Crown, M Clarke
Seminars in Oncology|December 29, 1998
Phase III studies of single-agent docetaxel in patients with metastatic breast cancer who have progressed despite previous chemotherapy regimens: preliminary resultsJ M Nabholtz, J Crown
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2012
Emerging targeted therapies in triple-negative breast cancerJ Crown, J O'Shaughnessy, G Gullo
Psycho-Oncology|September 19, 1998
The use of psychotropic medication in patients referred to a psycho-oncology serviceR Cullivan, J Crown, N Walsh
Leukemia & Lymphoma|April 1, 1993
Interleukin-1: biological effects in human hematopoiesisJ Crown, A Jakubowski, J Gabrilove
The Health Service Journal|February 22, 1990
A climate of trustP Howden-Chapman, A Waterfall, J Crown
Irish Medical Journal|November 1, 1995
Metastatic bone disease: role of bisphosphonatesM J McKenna, R Freaney, J Crown
British Journal of Hospital Medicine|September 1, 1989
Development of clinical auditJ Secker-Walker, H Purser, J Crown
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancerB Corkery, J Crown, M Clynes, et al.
Hematological Oncology|July 1, 1987
Large cell transformation of subclinical small lymphocytic leukemia/lymphoma: a variant of Richter's syndromeJ A Strauchen, M M May, J Crown
Pageof 11